Palmer pagon syndrome

disease
On this page

Also known as familial hydrocephalus with a low-insertion umbilicushydrocephaly - low insertion umbilicus

Summary

Palmer pagon syndrome (MONDO:0043164) is a disease. A subtype of hydrocephalus — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 10

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families2WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Signs & symptoms

Clinical features (HPO)

10 HPO clinical features (Orphanet curated; top 10 by frequency):

HPO IDTermFrequency
HP:0000079Abnormality of the urinary systemVery frequent (80-99%)
HP:0000286EpicanthusVery frequent (80-99%)
HP:0000445Wide noseVery frequent (80-99%)
HP:0000765Abnormal thorax morphologyVery frequent (80-99%)
HP:0001334Communicating hydrocephalusVery frequent (80-99%)
HP:0003189Long noseVery frequent (80-99%)
HP:0004299Hernia of the abdominal wallVery frequent (80-99%)
HP:0001636Tetralogy of FallotFrequent (30-79%)
HP:0001643Patent ductus arteriosusFrequent (30-79%)
HP:0010772Anomalous pulmonary venous returnFrequent (30-79%)

Identifiers

Disease identifiers

FieldValue
Canonical namepalmer pagon syndrome
Mondo IDMONDO:0043164
MeSHC538107
Orphanet2184
UMLSC2931734
MedGen419886
GARD0004199
Is cancer (heuristic)no

Also known as: familial hydrocephalus with a low-insertion umbilicus · hydrocephaly - low insertion umbilicus

Disease family

This is a subtype of hydrocephalus. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disordercentral nervous system disorderbrain disorderhydrocephaluspalmer pagon syndrome

Related subtypes (6): obstructive hydrocephalus, communicating hydrocephalus, craniosynostosis-Dandy-Walker malformation-hydrocephalus syndrome, congenital hydrocephalus, megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome, baker Vinters syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.